表皮生长因子受体
肺癌
医学
奥西默替尼
药物开发
癌症研究
表皮生长因子受体抑制剂
第一代
埃罗替尼
酪氨酸激酶
药品
癌症
药理学
肿瘤科
内科学
受体
环境卫生
人口
作者
Die Zhang,Jumei Zhao,Yue Yang,Qiangfang Dai,Ning Zhang,Zhikuan Mi,Qianqian Hu,Xiaolong Liu
标识
DOI：10.1080/14756366.2025.2481392
摘要
, binding modes, pharmacokinetics, as well as the advantages and disadvantages of each inhibitor, alongside the progress of clinical stage research related to fourth-generation inhibitors. Additionally, the review discusses future development directions for fourth-generation EGFR-TKIs, aiming to provide insights for successful research and development in this field.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
cdercder
潇洒的惋清
林金花
小荷才露尖尖角
无极微光
毛豆
七月不远
GingerF
OK
乐空思
东方元语
liuzhuohao
Copyright
老胡
Nole
青枫
初遇之时最暖
arniu2008
pluto
皖公网安备34019202002308
